These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 32567187)

  • 21. Deciphering the tumour microenvironment of clear cell renal cell carcinoma: Prognostic insights from programmed death genes using machine learning.
    Tu H; Hu Q; Ma Y; Huang J; Luo H; Jiang L; Zhang S; Jiang C; Lai H; Liu J; Chen J; Guo L; Yang G; Xu K; Chi H; Chen H
    J Cell Mol Med; 2024 Jul; 28(13):e18524. PubMed ID: 39011666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and
    Wen X; Hou J; Qi T; Cheng X; Liao G; Fang S; Xiao S; Qiu L; Wei W
    Front Immunol; 2024; 15():1427475. PubMed ID: 38953023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Data Mining of Prognostic Microenvironment-Related Genes in Clear Cell Renal Cell Carcinoma: A Study with TCGA Database.
    Chen B; Chen W; Jin J; Wang X; Cao Y; He Y
    Dis Markers; 2019; 2019():8901649. PubMed ID: 31781309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap.
    Shi B; Ding J; Qi J; Gu Z
    Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Cuproptosis-Related Prognostic Gene Signature and Validation of Differential Expression in Clear Cell Renal Cell Carcinoma.
    Bian Z; Fan R; Xie L
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma.
    Wu G; Li T; Chen Y; Ye S; Zhou S; Tian X; Anwaier A; Zhu S; Xu W; Hao X; Ye D; Zhang H
    Clin Exp Med; 2024 Jul; 24(1):152. PubMed ID: 38970690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
    Pang S; Zhao S; Dongye Y; Fan Y; Liu J
    Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction of a 12-Gene Prognostic Risk Model and Tumor Immune Microenvironment Analysis Based on the Clear Cell Renal Cell Carcinoma Model.
    Wang S; Yu Z; Cao Y; Du P; Ma J; Ji Y; Yang X; Zhao Q; Hong B; Yang Y; Hai Y; Li J; Mao Y; Wu S
    Cancer Control; 2024; 31():10732748241272713. PubMed ID: 39115042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma.
    Bao W; Han Q; Guan X; Wang Z; Gu M
    Oncol Res; 2023; 31(2):181-192. PubMed ID: 37304236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma.
    Liu JW; Supandi F; Dhillon SK
    Folia Biol (Praha); 2022; 68(1):1-15. PubMed ID: 36201853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.
    Wei X; Dong Y; Chen X; Ren X; Li G; Wang Y; Wang Y; Zhang T; Wang S; Qin C; Song N
    Aging (Albany NY); 2020 Nov; 12(23):24184-24207. PubMed ID: 33223511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of gene expression on survival of clear cell renal cell carcinoma.
    Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
    Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored.
    Yoon JY; Gedye C; Paterson J; Ailles L
    BMC Cancer; 2020 Apr; 20(1):272. PubMed ID: 32245446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel risk signature based on liquid-liquid phase separation-related genes reveals prognostic and tumour microenvironmental features in clear cell renal cell carcinoma.
    Lu Q; Xi P; Xu S; Zhang Z; Gong B; Liu J; Zhu Q; Sun T; Zhu S; Chen R
    Aging (Albany NY); 2024 Mar; 16(7):6118-6134. PubMed ID: 38546385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microenvironment-associated gene HSD11B1 may serve as a prognostic biomarker in clear cell renal cell carcinoma: a study based on TCGA, RT‑qPCR, Western blotting, and immunohistochemistry.
    Han D; Yu Z; Zhang H; Liu H; Wang B; Qian D
    Bioengineered; 2021 Dec; 12(2):10891-10904. PubMed ID: 34845968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.